Search results
3 Personal Finance Documentaries You Don't Want to Miss This Summer
CNET· 1 day agoHave you ever considered swapping your weekend TV show binge for a personal finance documentary?...
Powell Cheers Markets Looking for Signs on Rate Cuts
New York Times· 1 day agoThe S&P 500 winning streak rolled on after the Fed chair made encouraging comments about inflation and the state of the labor market. The S&P 500 is on a...
Double Fine: "Simple choices can have profound impact" on accessibility
gamesindustry.biz· 1 day agoDirector of development Kevin Johnson gave an overview of how the studio approaches accessibility...
A Look Back at Advertising Software Stocks' Q1 Earnings: PubMatic (NASDAQ:PUBM) Vs The Rest Of The...
StockStory via Yahoo Finance UK· 1 day agoIt currently trades at $84.67. Is now the time to buy AppLovin? Access our full analysis of the...
Reflecting On Leisure Products Stocks’ Q1 Earnings: Peloton (NASDAQ:PTON)
StockStory via Yahoo Finance UK· 1 day agoIt currently trades at $13.95. Is now the time to buy Smith & Wesson? Access our full analysis of...
Social Networking Stocks Q1 Results: Benchmarking Meta (NASDAQ:META)
StockStory via Yahoo Finance UK· 1 day agoIs now the time to buy Snap? Access our full analysis of the earnings results here, it's free....
Q1 Earnings Outperformers: Live Nation (NYSE:LYV) And The Rest Of The Leisure Facilities Stocks
StockStory via Yahoo Finance UK· 1 day agoAccess our full analysis of the earnings results here, it's free. Weakest Q1: Dave & Buster's...
Q1 Earnings Outperformers: DocuSign (NASDAQ:DOCU) And The Rest Of The Productivity Software Stocks
StockStory via Yahoo Finance UK· 1 day agoWrapping up Q1 earnings, we look at the numbers and key takeaways for the productivity software...
Building Materials Q1 Earnings: Carlisle (NYSE:CSL) Simply the Best
StockStory via Yahoo Finance UK· 1 day agoIs now the time to buy Armstrong World? Access our full analysis of the earnings results here, it's ...
Global Difficult to Express Protein Market is expected to ascend at a CAGR of 8.5% and is reaching U
PharmiWeb· 1 day agoThe market, valued at USD 4,218.4 million in 2023, is anticipated to reach USD 10.3 billion by the end of 2034. Technological advancements, particularly in cell free protein ...